The Lumpy Skin Disease outbreak impacting cattle has been addressed in India by immunizing cattle against the disease with the Goat Pox Vaccine.
Scientifically, the Goat Pox Vaccine (Uttarkashi Strain) may be used as a heterologous vaccine to immunize cattle against Lumpy Skin disease.
Hester acquired the technology for manufacturing the Goat Pox vaccine (Uttarkashi Strain) from Indian Veterinary Research Institute (IVRI) and commercialized the vaccine on 10 November 2014.
Hester currently has been supplying the Goat Pox Vaccine via respective state government tenders to immunize cattle against Lumpy Skin disease in the respective states.
Hester has also bid for the National Tender for supplying Goat Pox Vaccine for immunizing cattle against Lumpy Skin Disease.
In the current situation, Hester would like to inform that:
1. Hester recognized the early signs of a potential outbreak and initiated the manufacture of vaccine quantities in anticipation of surge in demand. As a result, Hester has been able to meet the complete demand raised on it for the supply of the Goat Pox vaccine in the country
2. There has been no short supply of the vaccine in any state in India
3. All supplies have been regularly made without any delays
In preparation towards manufacturing additional quantities of the Goat Pox vaccine as well as to ensure the continuance of the manufacturing and the supply of all other vaccines against poultry, sheep, goat and cattle, Hester is undergoing capacity expansion. This capacity expansion would be completed in January 2023.
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine. As soon as the technology is made available, Hester wil acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine.